Advertisement
Advertisement
Levare

Levare

levodropropizine

Manufacturer:

UNILAB, Inc

Distributor:

UNILAB, Inc
Concise Prescribing Info
Contents
Levodropropizine
Indications/Uses
Dosage/Direction for Use
Adult & childn ≥12 yr 1 tab tid w/ at least 6-hr interval. Max: 7 days.
Contraindications
Hypersensitivity. Patients w/ bronchorrhea & reduced mucociliary function (eg, Kartagener syndrome or bronchial cilia dyskinesia). Severe hepatic impairment. Pregnancy & lactation.
Special Precautions
Severe heart failure, diabetes, & severe renal impairment (CrCl <35 mL/min). May cause somnolence, dizziness & vertigo which may affect ability to drive vehicles or operating machinery.
Adverse Reactions
Allergic skin reaction, angioedema, hypersensitivity reaction; generalized edema, hypoglycemia; depersonalization, nervousness, stupor; coma, clouding of consciousness, dizziness, epilepsy, faint, headache, hypoglycemic coma, impaired consciousness, paresthesia, tremors, vertigo; bilateral blindness, mydriasis, palpebral edema, temporary loss of vision; arrhythmia, palpitations, tachycardia; hypotension; cough, dyspnea, pulmonary edema; abdominal distress, abdominal discomfort, aphthous fever, diarrhea, dyspepsia, glossitis, heartburn, nausea, vomiting; cholestatic hepatitis; epidermolysis, erythema, exanthema, itching, urticaria; hypotonia; asthenia, exhaustion, fatigue, malaise, irritability, weakness.
Drug Interactions
Caution when co-administered w/ benzodiazepines in sensitive patients.
MIMS Class
Cough & Cold Preparations
ATC Classification
R05DB27 - levodropropizine ; Belongs to the class of other cough suppressants.
Presentation/Packing
Form
Levare tab 60 mg
Packing/Price
100's
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement